Xianju Pharmaceutical announced that on May 14, 2026, the company reviewed and approved the share repurchase plan. It plans to use 80 million yuan to 150 million yuan to repurchase shares for equity incentives or employee stock ownership plans. The repurchase price will not exceed 13.25 yuan/share, and the implementation period will be 12 months. As of July 22, the company had repurchased 9.892,900 shares, accounting for 1.0001% of the total share capital. The highest transaction price was 8.58 yuan/share, the lowest transaction price was 7.92 yuan/share, and the total transaction amount was 81.9068 million yuan. In the future, we will continue to implement the repurchase plan and disclose information in a timely manner.

Xianju Pharmaceutical announced that on May 14, 2026, the company reviewed and approved the share repurchase plan. It plans to use 80 million yuan to 150 million yuan to repurchase shares for equity incentives or employee stock ownership plans. The repurchase price will not exceed 13.25 yuan/share, and the implementation period will be 12 months. As of July 22, the company had repurchased 9.892,900 shares, accounting for 1.0001% of the total share capital. The highest transaction price was 8.58 yuan/share, the lowest transaction price was 7.92 yuan/share, and the total transaction amount was 81.9068 million yuan. In the future, we will continue to implement the repurchase plan and disclose information in a timely manner.